Crossmark Global Holdings’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.54M | Buy |
63,238
+174
| +0.3% | +$16.4K | 0.06% | 279 |
|
|
2026
Q1 | $7.45M | Buy |
63,064
+1,089
| +2% | +$135K | 0.11% | 195 |
|
|
2025
Q4 | $7.8M | Buy |
61,975
+9,014
| +17% | +$1.18M | 0.11% | 190 |
|
|
2025
Q3 | $7.75M | Buy |
52,961
+3,949
| +8% | +$597K | 0.12% | 194 |
|
|
2025
Q2 | $7.64M | Buy |
49,012
+5,862
| +14% | +$930K | 0.12% | 195 |
|
|
2025
Q1 | $7.1M | Buy |
43,150
+6,214
| +17% | +$1.03M | 0.13% | 194 |
|
|
2024
Q4 | $6.02M | Buy |
36,936
+4,248
| +13% | +$760K | 0.11% | 209 |
|
|
2024
Q3 | $6.39M | Sell |
32,688
-1,897
| -5% | -$350K | 0.11% | 212 |
|
|
2024
Q2 | $6M | Sell |
34,585
-909
| -3% | -$151K | 0.11% | 207 |
|
|
2024
Q1 | $6.01M | Sell |
35,494
-86
| -0.2% | -$16.1K | 0.12% | 203 |
|
|
2023
Q4 | $7.02M | Sell |
35,580
-1,650
| -4% | -$292K | 0.15% | 167 |
|
|
2023
Q3 | $6.54M | Sell |
37,230
-1,457
| -4% | -$265K | 0.15% | 171 |
|
|
2023
Q2 | $7.35M | Sell |
38,687
-1,851
| -5% | -$320K | 0.16% | 167 |
|
|
2023
Q1 | $6.75M | Sell |
40,538
-1,270
| -3% | -$208K | 0.16% | 169 |
|
|
2022
Q4 | $6.13M | Buy |
41,808
+3,288
| +9% | +$487K | 0.15% | 174 |
|
|
2022
Q3 | $5.71M | Sell |
38,520
-1,613
| -4% | -$270K | 0.16% | 155 |
|
|
2022
Q2 | $6.9M | Sell |
40,133
-5,937
| -13% | -$1.03M | 0.18% | 146 |
|
|
2022
Q1 | $8.69M | Sell |
46,070
-352
| -0.8% | -$69.6K | 0.19% | 134 |
|
|
2021
Q4 | $11.3M | Buy |
46,422
+12,691
| +38% | +$2.78M | 0.25% | 108 |
|
|
2021
Q3 | $6.55M | Sell |
33,731
-214
| -0.6% | -$43.2K | 0.15% | 158 |
|
|
2021
Q2 | $6.33M | Sell |
33,945
-1,093
| -3% | -$190K | 0.15% | 160 |
|
|
2021
Q1 | $5.52M | Sell |
35,038
-160
| -0.5% | -$25.4K | 0.14% | 168 |
|
|
2020
Q4 | $5.83M | Sell |
35,198
-89
| -0.3% | -$14.5K | 0.15% | 162 |
|
|
2020
Q3 | $5.83M | Sell |
35,287
-2,139
| -6% | -$329K | 0.16% | 149 |
|
|
2020
Q2 | $5.13M | Sell |
37,426
-2,190
| -6% | -$286K | 0.15% | 153 |
|
|
2020
Q1 | $4.66M | Sell |
39,616
-574
| -1% | -$75.6K | 0.17% | 149 |
|
|
2019
Q4 | $5.32M | Sell |
40,190
-3,050
| -7% | -$379K | 0.15% | 161 |
|
|
2019
Q3 | $5.39M | Sell |
43,240
-3,206
| -7% | -$387K | 0.16% | 161 |
|
|
2019
Q2 | $5.27M | Sell |
46,446
-1,300
| -3% | -$136K | 0.15% | 170 |
|
|
2019
Q1 | $4.81M | Sell |
47,746
-366
| -0.8% | -$33.2K | 0.14% | 186 |
|
|
2018
Q4 | $4.12M | Sell |
48,112
-8,899
| -16% | -$801K | 0.13% | 200 |
|
|
2018
Q3 | $5.22M | Sell |
57,011
-4,933
| -8% | -$438K | 0.13% | 190 |
|
|
2018
Q2 | $5.28M | Sell |
61,944
-1,792
| -3% | -$151K | 0.14% | 177 |
|
|
2018
Q1 | $5.32M | Sell |
63,736
-8,991
| -12% | -$708K | 0.14% | 187 |
|
|
2017
Q4 | $5.24M | Buy |
72,727
+1,846
| +3% | +$127K | 0.13% | 203 |
|
|
2017
Q3 | $4.52M | Buy |
+70,881
| New | +$4.44M | 0.12% | 213 |
|
|
2016
Q3 | $4.52M | Buy |
+70,881
| New | +$3.59M | 0.12% | 213 |
|
Other funds holding ZTS
SI
MIHAS
FFM
CIM
SIM
DLA
Crossmark Global Holdings's ZTS Position: Q2 2026 in Review
Crossmark Global Holdings increased its Zoetis (ZTS) stake by 0.28% in Q2 2026, buying an estimated $16.4K and bringing the position to 63,238 shares worth $4.54M. The position accounts for 0.06% of the portfolio, ranked #279.
Crossmark Global Holdings first reported a position in ZTS in Q3 2016 and has held it in 37 quarters since. The position peaked at $11.3M in Q4 2021. 200 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.
- Crossmark Global Holdings held 63,238 shares of Zoetis worth $4.54M as of Q2 2026.
- Crossmark Global Holdings bought 174 Zoetis shares in Q2 2026, an estimated $16.4K.
- Zoetis made up 0.06% of Crossmark Global Holdings's portfolio in Q2 2026, its #279 holding.
- Crossmark Global Holdings first reported a position in Zoetis in Q3 2016 and has held it in 37 quarters since.
- Crossmark Global Holdings's Zoetis position peaked at $11.3M in Q4 2021.
- 200 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.